Iris van 't Erve

发表

Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases

G. Meijer, C. Punt, D. van den Broek, 2021, EBioMedicine.

Diagnostic strategies towards clinical implementation of liquid biopsy RAS/BRAF circulating tumor DNA analyses in patients with metastatic colorectal cancer.

V. Velculescu, G. Meijer, C. Punt, 2020, The Journal of molecular diagnostics : JMD.

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)

M. Lahaye, J. Burger, I. de Hingh, 2019, BMJ Open.

First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II)

J. Burger, I. de Hingh, M. Los, 2021, BMJ Open.

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

A. Zwinderman, J. Tuynman, R. Fehrmann, 2019, BMC Cancer.

Changes in Circulating Levels of 25-hydroxyvitamin D3 in Breast Cancer Patients Receiving Chemotherapy

D. Sommeijer, E. Kampman, M. Los, 2019, Nutrition and cancer.

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

A. Zwinderman, J. Tuynman, R. Fehrmann, 2019, BMC Cancer.

Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.

J. Tuynman, C. Punt, M. Lahaye, 2021, JAMA surgery.

KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases

V. Velculescu, G. Kazemier, G. Meijer, 2021, JCO precision oncology.

Reply to R. Pham et al.

G. Meijer, C. Punt, R. Fijneman, 2022, JCO Precision Oncology.

Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells

Samuel V. Angiuoli, Adith S. Arun, R. Scharpf, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Identifying Genetic Mutation Status in Patients with Colorectal Cancer Liver Metastases Using Radiomics-Based Machine-Learning Models

S. van Dieren, Z. Bodalal, R. Fijneman, 2023, Cancers.